Infectious complications following T-cell depleted hematopoietic stem-cell transplantation

被引:15
作者
Novitzky, N [1 ]
Rouskova, A [1 ]
机构
[1] Univ Cape Town, Groote Schuur Hosp, Dept Haematol, Ctr Leukaemia, ZA-7925 Cape Town, South Africa
关键词
T-cell depletion; sepsis; opportunistic infections; antibiotics;
D O I
10.1080/146532401753173990
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Background Although sepsis is a common complication during stem-cell transplantation, the prevalence of infections after hematopoietic recovery is less well known. Methods We undertook a retrospective analysis of infectious episodes in patients who underwent allogeneic BM (n = 77) or PBSC (n = 2 9) grafting,from HLA identical siblings. T-cell depletion of the stem-cell grafts with anti CD 52 (CAMPATH-1) Abs was employed for the prevention of GvHD. Results Patients' median age was 30 (4-54) years. Antibiotic prophylaxis was with oral amphotericin, ofloxacin and i.v. or oral aryclovir. Fever was treated empirically with a third generation cephalosporin and aminoglucosides until results of microbiological cultures became available. Six patients died of graft failure. GvHD was observed in 18% but in no case was it > Grade H. Only seven patients did not develop pyrexia during the initial admission or within 60 days following graft infusion. Median duration of pyrexia was 10 (range 2-49) days. A microbial source was detected in 42% and it was Gram (+) in 86%, Gram (-) in 11% and fungal in 3%. In 16 patients, indwelling venous catheters were removed due to severe infection. Subsequent to the recovery of the blood parameters, the most prevalent infection was by herpes varicella/zoster in 20; another 17 developed herpes simplex. In total 401102 were re-hospitalized for pyrexia, which in Jour cases was of unknown origin. Bacterial infections with Staphylococcus Aureus and S. Epidermitis were seen in 10 and seven patients respectively. CMV was detected in seven patients. Thirteen patients died of sepsis and in 10, it was related to GvHD or graft failure An other 2 0 died following recurrence of the malignancy. Overall, 39 patients died and 63% survived at a median DFS of 1992 (range 623-5092) days. Discussion We conclude that during the initial neutropenic period the dominant infections are by Gram (+) organisms; often associated with indwelling catheters. Once the BM has recovered, the main morbidity is by viral infections, but Gram+ organisms still remain common bacterial pathogens.
引用
收藏
页码:165 / 173
页数:9
相关论文
共 19 条
[1]   Influence of intestinal bacterial decontamination using metronidazole and ciprofloxacin or ciprofloxacin alone on the development of acute graft-versus-host disease after marrow transplantation in patients with hematologic malignancies:: Final results and long-term follow-up of an open-label prospective randomized trial [J].
Beelen, DW ;
Elmaagacli, A ;
Müller, KD ;
Hirche, H ;
Schaefer, UW .
BLOOD, 1999, 93 (10) :3267-3275
[2]   Febrile neutropenia in allogeneic and autologous peripheral blood stem cell transplantation and conventional chemotherapy for malignancies [J].
Çelebi, H ;
Akan, H ;
Akçaglayan, E ;
Üstün, C ;
Arat, M .
BONE MARROW TRANSPLANTATION, 2000, 26 (02) :211-214
[3]   Immune reconstitution after allogeneic bone marrow transplantation depleted of T cells [J].
Davison, GM ;
Novitzky, N ;
Kline, A ;
Thomas, V ;
Abrahams, L ;
Hale, G ;
Waldmann, H .
TRANSPLANTATION, 2000, 69 (07) :1341-1347
[4]  
DESJARDIN J, 1999, ANN INTERN MED, V9, P641
[5]   Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: A randomized, double-blind trial [J].
Feld, R ;
DePauw, B ;
Berman, S ;
Keating, A ;
Ho, W .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (21) :3690-3698
[6]   CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cells [J].
Hale, G ;
Jacobs, P ;
Wood, L ;
Fibbe, WE ;
Barge, R ;
Novitzky, N ;
du Toit, C ;
Abrahams, L ;
Thomas, V ;
Bunjes, D ;
Duncker, C ;
Wiesneth, M ;
Selleslag, D ;
Hidajat, M ;
Starobinski, M ;
Bird, P ;
Waldmann, H .
BONE MARROW TRANSPLANTATION, 2000, 26 (01) :69-76
[7]  
HICKMAN RO, 1979, SURG GYNECOL OBSTET, V148, P871
[8]  
HOYLE C, 1994, BONE MARROW TRANSPL, V14, P247
[9]   Fulminant hepatitis B following bone marrow transplantation in an HBsAg-negative, HBsAb-positive recipient; reactivation of dormant virus during the immunosuppressive period [J].
Iwai, K ;
Tashima, M ;
Itoh, M ;
Okazaki, T ;
Yamamoto, K ;
Ohno, H ;
Marusawa, H ;
Ueda, Y ;
Nakamura, T ;
Chiba, T ;
Uchiyama, T .
BONE MARROW TRANSPLANTATION, 2000, 25 (01) :105-108
[10]  
Jacobs P, 1991, J Clin Apher, V6, P54, DOI 10.1002/jca.2920060111